DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding DiaMedica Therapeutics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 45 | 57 | +12 |
| Shares | 6.73M | 7.51M | +785.1K (+11.7%) |
| Value | $36.5M | $28.5M | −$8.06M (−22.1%) |
New holders (14)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 56,703 | $214.0K | 0.00% |
| Jain Global LLC | 27,679 | $104.9K | 0.00% |
| Marshall Wace, LLP | 18,829 | $71.4K | 0.00% |
| Cornerstone Wealth Management, LLC | 16,250 | $61.6K | 0.00% |
| LMR Partners LLP | 15,167 | $57.5K | 0.00% |
| ExodusPoint Capital Management, LP | 13,343 | $51.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 12,480 | $47.3K | 0.01% |
| Diametric Capital, LP | 12,423 | $47.1K | 0.06% |
| SG Americas Securities, LLC | 10,878 | $41.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 3,209 | $12.2K | 0.00% |
| Wells Fargo & Company | 1,000 | $3.79K | 0.00% |
| Tower Research Capital LLC (TRC) | 738 | $2.80K | 0.00% |
| Point72 (DIFC) Ltd | 642 | $2.43K | 0.00% |
| Simplex Trading, LLC | 374 | $1.00K | 0.00% |
Sold out (2)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| 683 Capital Management, LLC | 76,116 | $413.3K |
| Legend Financial Advisors, Inc. | 1,000 | $5.43K |